Related Experiment Video
Updated: Jul 2, 2025

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection
Published on: May 23, 2016
Extracellular vesicles incorporating retrovirus-like capsids for the enhanced packaging and systemic delivery of mRNA
Wenchao Gu1, Sijin Luozhong1, Simian Cai2
1Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Abstract:
The blood-brain barrier (BBB) restricts the systemic delivery of messenger RNAs (mRNAs) into diseased neurons. Although leucocyte-derived extracellular vesicles (EVs) can cross the BBB at inflammatory sites, it is difficult to efficiently load long mRNAs into the EVs and to enhance their neuronal uptake. Here we show that the packaging of mRNA into leucocyte-derived EVs and the endocytosis of the EVs by neurons can be enhanced by engineering leucocytes to produce EVs that incorporate retrovirus-like mRNA-packaging capsids. We transfected immortalized and primary bone-marrow-derived leucocytes with DNA or RNA encoding the capsid-forming activity-regulated cytoskeleton-associated (Arc) protein as well as capsid-stabilizing Arc 5'-untranslated-region RNA elements. These engineered EVs inherit endothelial adhesion molecules from donor leukocytes, recruit endogenous enveloping proteins to their surface, cross the BBB, and enter the neurons in neuro-inflammatory sites. Produced from self-derived donor leukocytes, the EVs are immunologically inert, and enhanced the neuronal uptake of the packaged mRNA in a mouse model of low-grade chronic neuro-inflammation.
Insights
Researchers engineered leukocytes to produce extracellular vesicles (EVs) that efficiently package and deliver messenger RNAs (mRNAs) across the blood-brain barrier (BBB) into neurons. This novel method enhances mRNA delivery for treating neuro-inflammatory diseases.
Area of Science:
- Neuroscience
- Biotechnology
- Molecular Biology
Background:
- The blood-brain barrier (BBB) poses a significant challenge for delivering therapeutics, including messenger RNAs (mRNAs), to diseased neurons.
- Leukocyte-derived extracellular vesicles (EVs) show potential for crossing the BBB, but efficient mRNA loading and neuronal uptake remain difficult.
Purpose of the Study:
- To develop a method for enhancing mRNA packaging into leukocyte-derived EVs.
- To improve the ability of these engineered EVs to cross the BBB and be taken up by neurons.
Main Methods:
- Engineering leukocytes to produce EVs incorporating retrovirus-like mRNA-packaging capsids using the activity-regulated cytoskeleton-associated (Arc) protein.
- Transfecting leukocytes with DNA or RNA encoding Arc protein and Arc 5'-untranslated-region RNA elements.
- Evaluating EV characteristics, BBB crossing, neuronal uptake, and therapeutic effects in a mouse model of neuro-inflammation.
Main Results:
- Engineered EVs efficiently packaged and delivered long mRNAs into neurons.
- These EVs incorporated endothelial adhesion molecules, crossed the BBB at inflammatory sites, and were endocytosed by neurons.
- EVs derived from self-leukocytes were immunologically inert, enhancing mRNA delivery in a mouse model.
Conclusions:
- Engineering leukocytes with mRNA-packaging capsids is a viable strategy to enhance EV-mediated mRNA delivery across the BBB.
- This approach offers a promising, immune-tolerant method for delivering mRNA therapeutics to neurons in neuro-inflammatory conditions.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Retroviruses
Intralumenal Vesicles and Multivesicular Bodies
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
Intracellular Movement of Viruses and Bacteria

